SCHEMBL1132663

SCHEMBL1132663

CCc1ccccc1-c1c(C)cccc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 1/20 0.50
▸ TAAR1 Q96RJ0 1/20 0.43
▸ HTR7 P34969 1/20 0.43
▸ GABRA1 P14867 2/20 0.43
▸ GABRB2 P47870 2/20 0.43
▸ DHFR P00374 1/20 0.43
▸ HEXA P06865 1/20 0.42
▸ HEXB P07686 1/20 0.42
▸ CSNK2A2 P19784 1/20 0.42
▸ CSNK2B P67870 1/20 0.42
▸ CSNK2A1 P68400 1/20 0.42
▸ CSNK2A3 Q8NEV1 1/20 0.42
▸ CA1 P00915 2/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ PDK2 Q15119 1/20 0.41
▸ CA12 O43570 1/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6546133 0.87 TAAR1 (0.41) MYCTAAR1HTR7GABRA1GABRB2
SCHEMBL1133085 0.84 PDK2 (0.49) GABRA1GABRB2CSNK2A2CSNK2BCSNK2A1
SCHEMBL5599467 0.82 CSNK2A2 (0.49) TAAR1HTR7GABRA1GABRB2DHFR
SCHEMBL6546843 0.81 MYC (0.36) MYCTAAR1GABRA1GABRB2DHFR
SCHEMBL6547246 0.81 MYC (0.36) MYCTAAR1GABRA1GABRB2DHFR
SCHEMBL8537937 0.81 P2RX7 (0.45) TAAR1GABRA1GABRB2DHFRCSNK2A2
SCHEMBL5050611 0.80 MYC (0.44) MYCTAAR1HTR7CA1CA9
SCHEMBL28806791 0.79 PDCD1 (0.49) MYCHTR7CA1CA9CA2
SCHEMBL198461 0.78 CSNK2A2 (0.52) GABRA1GABRB2DHFRCSNK2A2CSNK2B
SCHEMBL28899579 0.78 MYC (0.58) MYCHTR7CA1CA9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2287141-B1 METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2015-10-21 — — EP disclosed
US-8237002-B2 Method for producing unsaturated organic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-07 — — US disclosed
US-20110046380-A1 METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-24 — — US disclosed
EP-2287141-A1 METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND Sumitomo Chemical Company, Limited (JP) 2011-02-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046380-A1 METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND NIT2, NOS1, CHRM1 MYC 2975/4885TAAR1 46/4885HTR7 2899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback